You searched for "correction"
How many injections in nAMD: ranibizumab vs. aflibercept
Intravitreal anti-VEGF injections make up a large proportion of the workload in ophthalmology clinics. Since the introduction of aflibercept with eight weekly injections there has been an option to use a treatment which may require less treatment, with potential cost...
Methotrexate and mycophenolate mofetil for non-infectious uveitis
This is the first reported randomised clinical trial comparing methotrexate versus mycophenolate mofetil (MMF) for the treatment of non-infectious intermediate uveitis, posterior uveitis or panuveitis. To be eligible for recruitment, patients had to be on ≥15mg oral prednisone and demonstrated...
Boston type I keratoprosthesis for limbal stem cell deficiency
Boston type I keratoprosthesis (KPro) long-term outcomes were compared in patients with and without limbal stem cell deficiency (LSCD) in this retrospective study. In the 11 year period 68 procedures were performed in individuals with LSCD, and 105 procedures in...Quiz Feb/Mar 2024
History A 21-month-old boy presented to his local ophthalmology department with a left proptotic eye from a growing cystic lesion known to be present from birth. Notes taken on presentation were: Known left microphthalmia with chorio-retinal coloboma, contralateral eye was...The clues of the eye – what is medical ophthalmology?
The author looks at the increasingly significant role of medical ophthalmologists and the importance of integrative healthcare. The eye is a remarkable organ, and for decades we have been discovering intimations of pathology existing elsewhere in the body [1] simply...Vitreomacular traction: natural course vs. vitrectomy vs. ocriplasmin
Over time, the vitreous gel completely separates from the retina in a process known as a posterior vitreous detachment (PVD). In some instances, however, the vitreous does not detach entirely and remains adherent to the macula. The term vitreomacular traction...Moorfields International Corneal & Cataract Symposium 2024
Mr Alexander Ionides & Mr Mark Wilkins, supported by Théa Pharmaceuticals, NuVison Biotherapies, Altomed Ltd. and Daybreak Medical, are pleased to invite you to register your place for the 2024 Moorfields International Corneal & Cataract Symposium! The programme is under construction and will include 14 talks on current Cornea & Cataract topics from Moorfields, UK and international keynote speakers. Confirmed keynote speakers include Dr Soosan Jacob from Dr Agarwal’s Group of Eye Hospitals, Chennai, India, Prof Adnan Tufail and Prof Paul Foster from Moorfields Eye Hospital NHS Foundation Trust. Thea are pleased to be the gold sponsors of this event along with Altomed, NuVision and Daybreak - silver sponsors.A tale of two membranes
It was the best of times, it was the worst of times... It was the season of Light, it was the season of Darkness... I am fortunate to work on a vitreoretinal firm at the moment and only a few...
